Inactive Instrument
Sector Cell Therapeutics Inc Nasdaq
Stocks
US1509348835
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 27/06/23 | DRI Healthcare Trust Receives US$54.8 Million in Debt Repayment | MT |
| 27/06/23 | DRI Healthcare Trust Announces USD 54.8 Million Debt Repayment from CTI Biopharma Corp | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +0.65% | -3.36% | -11.99% | +15.75% | +57.11% | +36.98% | +60.50% | +6.07% | - | 64.14B | |
| +0.78% | +2.45% | -5.40% | +3.48% | +11.97% | +12.00% | +83.49% | +210.00% | +5,632.86% | 55.53B | |
| +0.81% | +1.08% | +8.73% | +10.47% | +18.07% | +12.27% | +103.85% | -15.40% | +239.94% | 53.03B | |
| +2.76% | +0.87% | +2.98% | +14.86% | +23.79% | +27.92% | +55.07% | +8.50% | +288.80% | 45.99B | |
| +2.00% | -3.39% | +1.73% | +12.98% | +22.89% | +17.83% | +119.04% | +2.41% | +1,015.51% | 42.45B | |
| +1.34% | -2.86% | -6.45% | +2.64% | +136.94% | +224.43% | +914.08% | +534.35% | - | 40.45B | |
| +0.64% | -3.95% | +6.45% | +6.99% | +10.10% | +11.15% | +45.57% | +7.13% | +158.47% | 32.25B | |
| -2.56% | +42.65% | +63.40% | +102.79% | +86.78% | +103.66% | +90.16% | +31.28% | +238.64% | 34.47B | |
| -2.72% | -0.44% | -15.78% | +14.42% | +43.32% | +23.18% | -10.77% | -61.94% | - | 24.23B | |
| +1.07% | -3.61% | -11.19% | -4.82% | -7.57% | -16.22% | -3.52% | -69.02% | - | 22.1B | |
| +2.13% | +3.13% | -17.58% | -6.87% | -44.28% | -41.33% | +306.11% | +227.75% | +616.25% | 21.18B | |
| +2.80% | +4.56% | +12.46% | +21.32% | +23.33% | +19.32% | +176.76% | +215.27% | +2,297.65% | 19.38B | |
| +4.22% | +8.44% | +26.95% | +55.55% | +87.48% | +99.00% | +116.69% | -14.77% | +392.08% | 17.85B | |
| +0.14% | +3.72% | +13.33% | +25.82% | +38.40% | +42.51% | +84.81% | -15.28% | +108.65% | 16.69B | |
| +1.42% | +2.63% | +13.55% | +17.29% | +51.22% | +65.39% | +228.12% | +204.60% | +509.19% | 16.42B | |
| +1.50% | +4.46% | +8.48% | -1.92% | - | - | - | - | - | 16.39B | |
| +0.84% | +2.13% | +3.90% | +7.62% | +183.22% | +166.23% | +345.61% | +1,427.61% | +795.27% | 15.33B | |
| +17.04% | +15.61% | +21.98% | +18.82% | +17.53% | +20.50% | -8.99% | -25.23% | +166.63% | 16.04B | |
| +0.97% | -2.23% | -7.44% | -12.02% | +11.63% | +3.84% | +435.21% | - | - | 13.21B | |
| Average | +1.88% | +3.90% | +5.69% | +16.06% | +42.88% | +46.04% | +174.54% | +157.25% | +958.46% | 29.85B | |
| Weighted average by Cap. | +1.41% | +3.56% | +4.15% | +16.42% | +41.56% | +45.25% | +165.01% | +120.80% | +1,254.06% |
- Stock Market
- Stocks
- CTIC Stock
- Stock
- Sector Cell Therapeutics Inc
Select your edition
All financial news and data tailored to specific country editions
